What Is CJC-1295? A Research Peptide Overview
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), studied in laboratory research.
Chemical properties
- Base: Modified GRF(1-29) with four amino acid substitutions for stability
- DAC variant: Adds a Drug Affinity Complex for albumin binding
- Molecular weight (DAC): ~3,647.2 g/mol
- Appearance: White to off-white lyophilized powder
What CJC-1295 is studied for
In laboratory research:
- GHRH receptor — acts as an agonist at the GHRH receptor
- Growth hormone release — stimulates GH release from pituitary cells in vitro
- Pharmacokinetics — the DAC modification extends half-life via albumin binding
How CJC-1295 is verified
- HPLC — purity >=99% by peak area
- Mass spectrometry — observed mass matching theoretical mass
- LAL endotoxin — below research-grade thresholds
Buy CJC-1295 with DAC from Peptech ->
FAQ
What is CJC-1295?
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) studied in laboratory research. The DAC variant includes a Drug Affinity Complex that extends its half-life.
What is the difference between CJC-1295 and CJC-1295 with DAC?
CJC-1295 without DAC is Modified GRF(1-29) with a short half-life. CJC-1295 with DAC includes a Drug Affinity Complex that binds serum albumin, extending the research half-life.